Literature DB >> 12829927

Cyclosporine excretion into breast milk.

Myla E Moretti1, Michael Sgro, David W Johnson, Reg S Sauve, Mary J Woolgar, Anna Taddio, Zul Verjee, Esther Giesbrecht, Gideon Koren, Shinya Ito.   

Abstract

Although many female patients of childbearing age who are receiving cyclosporine have successful pregnancies, these women may be advised not to breast-feed. During recent years, cases of uneventful pregnancies and subsequent successful breast-feeding have been reported in the literature. The infant's blood cyclosporine concentration was usually very low. Based on these findings and the lack of detectable adverse effects, some investigators have suggested that women on cyclosporine may breast-feed, challenging the conventional view that cyclosporine is contraindicated during breast-feeding. Here, we report our experience with cyclosporine use during breast-feeding in five mother-infant pairs. We show a wide range of infant exposures to the drug in milk, noting that one of the infants had therapeutic blood concentrations of cyclosporine despite relatively low concentrations of the drug in milk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829927     DOI: 10.1097/01.TP.0000066352.86763.D0

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

Review 1.  Breast is best for babies.

Authors:  Alexander K C Leung; Reginald S Sauve
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

Review 2.  Pharmacological Approach to Managing Childhood-Onset Systemic Lupus Erythematosus During Conception, Pregnancy and Breastfeeding.

Authors:  Nicole Bitencourt; Bonnie L Bermas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

Review 3.  Outcomes of Children with Fetal and Lactation Immunosuppression Exposure Born to Female Transplant Recipients.

Authors:  Cameron J McKinzie; Jillian P Casale; Jack C Guerci; Alyson Prom; Christina T Doligalski
Journal:  Paediatr Drugs       Date:  2022-07-23       Impact factor: 3.930

Review 4.  Management of Inflammatory Bowel Disease During Pregnancy.

Authors:  Ariella Bar-Gil Shitrit; Sorina Grisaru-Granovsky; Ami Ben Ya'acov; Eran Goldin
Journal:  Dig Dis Sci       Date:  2016-04-11       Impact factor: 3.199

Review 5.  From conception to delivery: managing the pregnant inflammatory bowel disease patient.

Authors:  Vivian W Huang; Flavio M Habal
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 6.  Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease.

Authors:  Sumona Saha; Arnold Wald
Journal:  Expert Opin Drug Saf       Date:  2012-09-06       Impact factor: 4.250

7.  ACG Clinical Guideline: Liver Disease and Pregnancy.

Authors:  Tram T Tran; Joseph Ahn; Nancy S Reau
Journal:  Am J Gastroenterol       Date:  2016-02-02       Impact factor: 10.864

Review 8.  Ciclosporin use during pregnancy.

Authors:  Karolina Paziana; Magaly Del Monaco; Elyce Cardonick; Michael Moritz; Matthew Keller; Bruce Smith; Lisa Coscia; Vincent Armenti
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

Review 9.  Reproductive health in women following abdominal organ transplant.

Authors:  Monika Sarkar; Kate Bramham; Michael J Moritz; Lisa Coscia
Journal:  Am J Transplant       Date:  2018-03-30       Impact factor: 8.086

Review 10.  The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.

Authors:  Cecilia Beatrice Chighizola; Voon H Ong; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.